Effect of the subcutaneous low molecular weight heparin injection technique on bruising and pai

Phase 3

Completed

• Conditions: DVT; Deep Venous Thrombosis

• Registration Number: TCTR20160426004
• Lead Sponsor: Siriraj Resarch Development Fund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-04-26
• Study Completion: 2016-07-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

age 18- 80 y
Outpatient who receive Enoxaparin 1 mg/kg twice daily

Exclusion Criteria

-Patients who have mental disorder that affects the brain and perception.
-receiving the drug. anticoagulant and antiplatelet addition
-Creatinine clearance < 30 ml/mi,Platelet ≤ 100,000 /ul,APTT ≤ 23 or ≥ 32 sec, PT ≤ 11 or ≥ 14 sec
-pregnancy or breastfeeding
-cann't follow up

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
briuse rate 48 hrs.and 60 hrs after patient's injection percent

Secondary Outcome Measures

Name	Time	Method
briuse area and pain level 48 hrs.and 60 hrs after patient's injection area measurement and NRS